Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pixantrone

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Pixantrone?

Pixantrone is an investigational drug.

There have been 18 clinical trials for Pixantrone. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2004.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Lymphoma, B-Cell. The leading clinical trial sponsors are CTI BioPharma, Theradex, and Johannes Gutenberg University Mainz.

Recent Clinical Trials for Pixantrone
Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin LymphomaThe Lymphoma Academic Research OrganisationPhase 2
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory CancerCTI BioPharmaPhase 1
Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN StudyUniversity of AarhusPhase 1/Phase 2

See all Pixantrone clinical trials

Clinical Trial Summary for Pixantrone

Top disease conditions for Pixantrone
Top clinical trial sponsors for Pixantrone

See all Pixantrone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.